Literature DB >> 9127222

Iliac crest donor site morbidity in foot and ankle surgery.

S D Schulhofer1, L M Oloff.   

Abstract

The authors retrospectively reviewed anterior iliac crest donor site morbidity in 40 consecutive patients (42 donor sites) who underwent graft harvesting for reconstructive foot or ankle surgery. The mean time to follow-up was 22 months (range, 1 to 48 months). The overall complication rate was 2.4%, with one early minor complication and no major complications. The authors conclude that anterior iliac crest-harvesting techniques that rely on minimal soft tissue dissection and the removal of small-to-moderate volumes of bone have reduced frequencies of minor and major donor site complications.

Entities:  

Mesh:

Year:  1997        PMID: 9127222     DOI: 10.1016/s1067-2516(97)80064-6

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  4 in total

1.  Modified Lapidus Procedure with Joint Compression, Meticulous Surface Preparation, and Shear-Strain-Relieved Bone Graft Yields Low Nonunion Rate.

Authors:  Sriniwasan B Mani; Eric W Lloyd; Aoife MacMahon; Matthew M Roberts; David S Levine; Scott J Ellis
Journal:  HSS J       Date:  2015-08-29

Review 2.  The role of orthobiologics in foot and ankle surgery: Allogenic bone grafts and bone graft substitutes.

Authors:  James Wee; Gowreeson Thevendran
Journal:  EFORT Open Rev       Date:  2017-06-01

Review 3.  Innovative Concepts and Recent Breakthrough for Engineered Graft and Constructs for Bone Regeneration: A Literature Systematic Review.

Authors:  Francesco Inchingolo; Denisa Hazballa; Alessio Danilo Inchingolo; Giuseppina Malcangi; Grazia Marinelli; Antonio Mancini; Maria Elena Maggiore; Ioana Roxana Bordea; Antonio Scarano; Marco Farronato; Gianluca Martino Tartaglia; Felice Lorusso; Angelo Michele Inchingolo; Gianna Dipalma
Journal:  Materials (Basel)       Date:  2022-01-31       Impact factor: 3.623

4.  Midterm outcomes of midfoot and hindfoot arthrodesis with strut allograft for Müller-Weiss disease.

Authors:  Tung-Ying Lee; Chang-Chin Wu; Kai-Chiang Yang; Kuang-Ting Yeh; Ing-Ho Chen; Chen-Chie Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-07-27       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.